 Momenta Pharmaceuticals, Inc. NASDAQ:MNTA Investment analysts at Piper Sandler lowered their Q2 2020 earnings per share EPS estimates for shares of Momenta Pharmaceuticals in a note issued to investors on Monday, June 15th. Piper Sandler analyst T. Van. Buren now expects that the biotechnology company will earn 0.40 per share for the quarter, down ... 